Evaluation of supplemental testing with the Multispot HIV-1/HIV-2 Rapid Test and APTIMA HIV-1 RNA Qualitative Assay to resolve specimens with indeterminate or negative HIV-1 Western blots

Journal of Clinical Virology

Volumn 58, Issue SUPPL1, 2013, Pages

  Linley, Laurie ^a   Ethridge, Steven F ^a   Oraka, Emeka ^b   Owen, S Michele ^a   Wesolowski, Laura G ^a   Wroblewski, Kelly ^c   Landgraf, Kenneth M ^c   Parker, Monica M ^d   Brinson, Myra ^e   Branson, Bernard M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ICF INTERNATIONAL   (United States)

^c ASSOCIATION OF PUBLIC HEALTH LABORATORIES   (United States)

^d WADSWORTH CENTER   (United States)

^e North Carolina State Laboratory of Public Health   (United States)

Author keywords

Acute HIV infection; Algorithm; HIV testing; HIV 1 NAT; HIV 1 HIV 2 Rapid Test; Western blot

Indexed keywords

ALGORITHM; ARTICLE; DIAGNOSTIC KIT; DIAGNOSTIC TEST; EVALUATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WESTERN BLOTTING;

ACUTE HIV INFECTION; ALGORITHM; HIV TESTING; HIV-1 NAT; HIV-1/HIV-2 RAPID TEST; IA; IMMUNOASSAY; WB; WESTERN BLOT;

ALGORITHMS; BLOTTING, WESTERN; CLINICAL LABORATORY TECHNIQUES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; VIROLOGY;

EID: 84890151640     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.09.021     Document Type: Article

References (25)

1. Centers for Disease Control Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type I infections. Morb Mortal Wkly Rep 1989, 38(Suppl. 7):1-7.
2. Masciotra S., McDougal J.S., Feldman J., Sprinkle P., Wesolowski L., Owen S.M. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. J Clin Virol 2011, 52(Suppl. 1):S57-S61.
3. Busch M.P., Satten G.A. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med 1997, 102(5B):117-124.
4. Branson B.M. The future of HIV testing. J Acquir Immune Defic Syndr 2010, 55(Suppl. 2):S102-S105.
5. Wesolowski L.G., Delaney K.P., Hart C., Dawson C., Owen S.M., Candal D., et al. Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors. J Clin Virol 2011, 52(Suppl. 1):S45-S49.
6. Delaney K.P., Heffelfinger J.D., Wesolowski L.G., Owen S.M., Meyer III W.A., Kennedy S. Performance of an alternative laboratory-based algorithm for HIV diagnosis in a high-risk population. J Clin Virol 2011, 52(Suppl. 1):S5-S10.
7. Torian L.V., Forgione L.A., Punsalang A.E., Pirillo R.E., Oleszko W.R. Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV. J Clin Virol 2011, 52(Suppl. 1):S41-S44.
8. Styer L.M., Sullivan T.J., Parker M.M. Evaluation of an alternative supplemental testing strategy for HIV diagnosis by retrospective analysis of clinical HIV testing data. J Clin Virol 2011, 52(Suppl. 1):S35-S40.
9. Clinical and Laboratory Standards Institute (CLSI) Criteria for laboratory testing and diagnosis of human immunodeficiency virus infection; approved guideline 2011, Document No. M53-A.
10. Hologic Gen-Probe Incorporated APTIMA HIV-1 RNA qualitative assay 2009, Hologic Gen-Probe Incorporated, San Diego, CA.
11. Bio-Rad Laboratories Multispot HIV-1/HIV-2 rapid test 2013, Bio-Rad Laboratories, Redmond, WA.
12. Owen S.M., Yang C., Spira T., Ou C.Y., Pau C.P., Parekh B.S., et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol 2008, 46(5):1588-1595.
13. Patel P., Mackellar D., Simmons P., Uniyal A., Gallagher K., Bennet B., et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med 2010, 170(1):66-74.
14. Wesolowski L.G., Delaney K.P., Meyer W.A., Blatt A.J., Bennett B., Chavez P., et al. Use of rapid HIV assays as supplemental tests in specimens with repeatedly reactive screening immunoassay results not confirmed by HIV-1 Western blot. J Clin Virol 2013, 58(1):240-244.
15. Albritton W.L., Vittinghoff E., Padian N.S. Human immunodeficiency virus testing for patient-based and population-based diagnosis. J Inf Dis 1996, 174(Suppl. 2):S176-S181.
16. Ginocchio C.C., Wang X., Kaplan M.H., Mulligan G., Witt D., Romano J.W., et al. Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol 1997, 35(11):2886-2893.
17. Valentine-Thon E. Quality control in nucleic acid testing: where do we stand?. J Clin Virol 2002, 25(Suppl. 3):S13-S21.
18. Heffelfinger J., Delaney K., Owen M., Candal D., Kennedy S., Uniyal A., et al. Ability of the Genprobe APTIMA HIV-1 RNA qualitative assay to confirm reactive rapid HIV screening tests. Poster Session Presented at: 16th Conference on Retroviruses and Opportunistic Infections 2009, #993.
19. Nugent C.T., Nodelman V., Giachetti C., Richman D.D., Looney D.J. Evaluation of a highly sensitive qualitative human immunodeficiency virus type 1 (HIV-1) RNA assay for detection of HIV-1 suppression. J Clin Microbiol 2009, 47(3):833-836.
20. Pilcher C.D., Joaki G., Hoffman I.F., Martinson F.E., Mapanje C., Stewart P.W., et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 2007, 21(13):1723-1730.
21. Wawer M.J., Gray R.H., Sewankambo N.K., Serwadda D., Li X., Laeyendecker O., et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005, 191(9):1403-1409.
22. Brenner B.G., Roger M., Routy J.P., Moisi D., Ntemgwa M., Matte C., et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007, 195(7):951-959.
23. Pilcher C.D., Christopoulos K.A., Golden M. Public health rationale for rapid nucleic acid or p24 antigen tests for HIV. J Infect Dis 2010, 201(Suppl. 1):S7-S17.
24. Cohen M.S., Shaw G.M., McMichael A.J., Haynes B.F. Acute HIV-1 infection. N Engl J Med 2011, 364:1943-1954.
25. Owen S.M. Testing for acute HIV infection: implications for treatment as prevention. Curr Opin HIV AIDS 2012, 7:125-130.